United States · FDA National Drug Code directory
Prevalite
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0245-0036_44feb603-0970-9b63-e063-6294a90a7ce5
- Product NDC
- 0245-0036
- Form
- POWDER, FOR SUSPENSION
- Composition / generic term
- cholestyramine
- Labeler
- Upsher-Smith Laboratories, LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 19960201 / 20271031
Source-listed ingredients
- CHOLESTYRAMINE — 4 g/5.5g
These values do not establish equivalence or a dose recommendation.
Packages
- 231 g in 1 CAN (0245-0036-23) · 0245-0036-23
- 42 PACKET in 1 CARTON (0245-0036-42) / 5.5 g in 1 PACKET (0245-0036-89) · 0245-0036-42
- 60 PACKET in 1 CARTON (0245-0036-60) / 5.5 g in 1 PACKET (0245-0036-89) · 0245-0036-60
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →